頭蓋内動脈瘤市場：タイプ、適応症、エンドユーザー別-2024-2030年の世界予測

頭蓋内動脈瘤市場規模は2023年に13億2,000万米ドルと推計され、2024年には16億米ドルに達し、CAGR 22.16％で2030年には53億8,000万米ドルに達すると予測されています。

頭蓋内動脈瘤市場は、頭蓋内の動脈壁の膨隆やバルーン（膨らみ）の診断、治療、管理に焦点を当てたヘルスケア産業分野です。同市場には、診断機器、手術器具、薬剤、外科的・非外科的介入を含む幅広い治療オプションなど、様々な製品やサービスが含まれます。頭蓋内動脈瘤市場の成長は、世界人口の高齢化、高血圧や喫煙の有病率の増加、医療画像技術の進歩、疾患に対する一般市民の意識の高まりといった要因に影響されています。さらに、ヘルスケアインフラの改善、医療支出の増加、低侵襲手術に対する需要の高まりも市場拡大に寄与しています。頭蓋内動脈瘤市場の成長に影響を与える限界としては、高い治療費、低開発地域や新興国開拓地域における医療施設へのアクセスの制限、侵襲的な外科手術に伴うリスクなどが挙げられます。これらに加えて、製品承認に関する厳しい規制の枠組みや、専門的な介入を行うことができる熟練した専門家の必要性もあります。しかし市場は、より効果的で侵襲の少ない治療技術の開拓、画像診断や診断の強化のための人工知能の応用、血管内治療に使用されるステントやコイルへの新規生体材料の導入など、新たな潜在的機会を目の当たりにしています。さらに、遺伝子研究の進歩は、早期発見や個別化治療戦略につながる可能性があります。

タイプ小型の嚢状動脈瘤に対する血管内コイリングなどの低侵襲技術の需要

動脈閉塞術およびバイパス術は、侵襲性の低い方法では治療が困難または危険であると考えられる場合に利用される外科的介入です。これらの手技では、患部の動脈を閉鎖し、脳循環を維持するために血管移植片を用いて血流を迂回させる。この手技は通常、血管内治療が適応とならない複雑な動脈瘤や、これまでの治療が失敗した場合にのみ行われます。血管内コイリングは低侵襲の手技で、動脈にカテーテルを挿入し、動脈瘤部位まで誘導します。その後、柔らかい金属コイルをカテーテルを通して動脈瘤内に展開し、血液凝固を促進して動脈瘤内への血流を防ぎ、破裂のリスクを低減します。血管内コイリングは開腹手術に比べて侵襲が少なく、回復に要する時間も短いため、多くの頭蓋内動脈瘤の治療にしばしば選択されています。フローダイバータは大動脈瘤や巨大動脈瘤を治療するためにデザインされた血管内留置器具であり、コイリングに適さない基部の広い動脈瘤を治療します。これらのステントのような器具は動脈瘤の頸部を横切って設置され、血流を動脈瘤嚢から遠ざける。時間の経過とともに、これは動脈瘤内の血栓症を引き起こし、影響を受けた血管セグメントの再建につながります。フローダイバータは親動脈の血流を維持しながら動脈瘤を閉塞させるのに有効です。外科的クリッピング術は、動脈瘤を露出させるための開頭術を伴う頭蓋内動脈瘤に対する伝統的かつ決定的な治療法です。その後、脳神経外科医が動脈瘤の基部に小さな金属クリップを留置し、動脈血流から効果的に隔離します。これにより動脈瘤の成長や破裂を防ぐことができます。この手技は侵襲的で回復に時間がかかるが、長期的な成功率が高く、耐久性のある解決策です。

エンドユーザー：早期スクリーニングと診断サービスを求めるクリニック全体の患者数の増加

診療所、特に神経学と放射線学を専門とする診療所は、頭蓋内動脈瘤の診断と治療のためのサービスを提供しています。これらの施設は通常、病院よりも小規模で、早期診断、外来診療、利便性から患者に好まれることが多いです。病院は、頭蓋内動脈瘤管理における最も包括的な最終用途分野であり、診断、手術、術後ケアの全領域を提供します。病院には通常、動脈瘤治療の正確な診断と術前計画に不可欠な高解像度MRIやCTスキャナーなどの高度な神経画像技術が備わっています。病院では、訓練を受けた神経インターベンション放射線科医や神経外科医がいる設備の整った手術室で、マイクロサージャリー・クリッピングなどの開腹手術や、コイリングや流路転換などの血管内治療が行われます。治療後、病院は特に侵襲的な手術後や動脈瘤破裂などの合併症が発生した場合に、患者をモニタリングするための集中治療室を提供します。

地域別の洞察

南北アメリカでは、頭蓋内動脈瘤の有病率は遺伝的、環境的、ライフスタイル的要因の組み合わせに影響されます。医療インフラや、頭蓋内動脈瘤を含む神経疾患の調査に多額の投資が行われています。米国とカナダは、外科的介入や低侵襲手技を含め、高い診断率と治療率を誇る先進的なヘルスケアシステムを有しています。EMEA地域では、欧州で頭蓋内動脈瘤の調査と管理が盛んに行われており、多くの国でコイリングや流路転換などの最新の血管内治療が採用されています。中東では、ニューロインターベンション施設の利用可能性が高まり、ヘルスケアインフラが成長しています。しかし、EMEA全域で社会経済や医療制度が多様であるため、有病率や管理方法にはばらつきがあります。アフリカは医療資源が限られているため課題に直面しているが、主要都市部では進展が続いています。アジア太平洋地域では、頭蓋内動脈瘤の情勢は多様です。日本や韓国を含む国々は、技術導入率が高く、医療の革新に力を入れています。中国やインドなどの国々はヘルスケアインフラを急速に整備しており、神経血管治療へのアクセスを向上させています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは頭蓋内動脈瘤市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、頭蓋内動脈瘤市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いで直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.頭蓋内動脈瘤市場の市場規模および予測は？

2.頭蓋内動脈瘤市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.頭蓋内動脈瘤市場の技術動向と規制枠組みは？

4.頭蓋内動脈瘤市場における主要ベンダーの市場シェアは？

5.頭蓋内動脈瘤市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 生活習慣の変化による脳血管障害の罹患率の上昇
    • 低侵襲頭蓋内動脈瘤処置の傾向
    • 頭蓋内動脈瘤の診断の改善
  • 抑制要因
    • 治療に伴う副作用と治療費の高騰
  • 機会
    • 研究開発活動の活発化と革新的技術製品のイントロダクション
    • 血管内コイル塞栓術の可能性の高まり
  • 課題
    • 手術と麻酔導入のタイミングに関する問題
• 市場セグメンテーション分析
  • タイプ：より小さな嚢状動脈瘤に対する血管内コイル塞栓術などの低侵襲技術の需要
  • エンドユーザー：早期スクリーニングおよび診断サービスを求めるクリニック間の患者流入の増加
• 市場動向分析
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析
• 顧客のカスタマイズ

第6章 頭蓋内動脈瘤市場：タイプ別

• 動脈閉塞とバイパス
• 血管内コイル塞栓術
• フローダイバータ
• 外科的クリッピング

第7章 頭蓋内動脈瘤市場適応症別

• 破裂した動脈瘤
• 未破裂動脈瘤

第8章 頭蓋内動脈瘤市場：エンドユーザー別

• クリニック
• 病院

第9章 南北アメリカの頭蓋内動脈瘤市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の頭蓋内動脈瘤市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの頭蓋内動脈瘤市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • エヴァスクは臨床マイルストーンを発表し、ドイツの子会社とともに欧州でのプレゼンスを拡大する計画を発表
  • OUの研究者が脳動脈瘤の治療を改善するデバイスを設計

第13章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. INTRACRANIAL ANEURYSM MARKET RESEARCH PROCESS
• FIGURE 2. INTRACRANIAL ANEURYSM MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. INTRACRANIAL ANEURYSM MARKET DYNAMICS
• FIGURE 7. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. INTRACRANIAL ANEURYSM MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. INTRACRANIAL ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. INTRACRANIAL ANEURYSM MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ARTERY OCCLUSION & BYPASS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ARTERY OCCLUSION & BYPASS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ENDOVASCULAR COILING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ENDOVASCULAR COILING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY SURGICAL CLIPPING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY SURGICAL CLIPPING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY RUPTURED ANEURYSM, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY RUPTURED ANEURYSM, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY UNRUPTURED ANEURYSM, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY UNRUPTURED ANEURYSM, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY CLINICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY CLINICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 30. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 31. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 32. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 33. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 34. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 35. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 36. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 37. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 38. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 39. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 40. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 41. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 42. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 43. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 44. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 45. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 46. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 47. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 48. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 49. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 50. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 51. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 52. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 53. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 54. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 55. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 56. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 57. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 58. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 59. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 60. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 61. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 62. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 63. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 64. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 65. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 66. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 67. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 68. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 70. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 72. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 74. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 76. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 77. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 78. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 79. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 80. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 81. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 82. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 83. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 84. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 85. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 86. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 87. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 88. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 89. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 90. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 91. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 92. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 93. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 94. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 95. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 96. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 97. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 98. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 99. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 100. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 101. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 102. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 103. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 104. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 105. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 106. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 107. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 108. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 109. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 110. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 111. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 112. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 113. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 114. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 115. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 116. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 117. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 118. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 119. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 120. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 121. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 122. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 123. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 124. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 126. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 128. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 130. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 131. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 132. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 133. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 134. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 135. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 136. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 137. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 138. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 139. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 140. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 141. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 142. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 143. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 144. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 145. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 146. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 147. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 148. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 157. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 158. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 159. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 160. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 161. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 162. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 163. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 164. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 165. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 166. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 167. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 168. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 169. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 170. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 171. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 172. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 173. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 174. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 175. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 176. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 177. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 178. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 179. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 180. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 181. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 182. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 183. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 184. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 185. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 186. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 187. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 188. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 189. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 190. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 191. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 192. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 193. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 194. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 195. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 196. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 197. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 198. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 199. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 200. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 201. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 202. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 203. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 204. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 205. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 206. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 207. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 208. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 209. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 210. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 211. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 212. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 213. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 214. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 215. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 216. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 217. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 218. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 219. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 220. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 221. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 222. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 223. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 224. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 225. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 226. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 227. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 228. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 229. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 230. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 231. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 232. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 233. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 234. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 236. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 238. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 240. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 242. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 244. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 246. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 247. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 248. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 249. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 250. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 251. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 252. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 253. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 254. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 255. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 256. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 257. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 258. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 259. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 260. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 261. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 262. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 263. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 264. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 265. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 266. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 267. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 268. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 269. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 270. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 278. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 280. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 282. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 283. INTRACRANIAL ANEURYSM MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 284. INTRACRANIAL ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2023

[186 Pages Report] The Intracranial Aneurysm Market size was estimated at USD 1.32 billion in 2023 and expected to reach USD 1.60 billion in 2024, at a CAGR 22.16% to reach USD 5.38 billion by 2030.

The intracranial aneurysm market is the healthcare industry sector focused on diagnosing, treating, and managing intracranial aneurysms, bulges, or ballooning in the walls of arteries within the cranium. The market includes various products and services such as diagnostic equipment, surgical tools, medications, and a wide range of treatment options, including surgical and non-surgical interventions. Growth in the intracranial aneurysm market is influenced by factors such as the aging global population, the increasing prevalence of hypertension and smoking, advancements in medical imaging technologies, and the rise in public awareness about the condition. Additionally, improvements in healthcare infrastructure, increased healthcare spending, and the growing demand for minimally invasive surgeries contribute to market expansion. Limitations affecting the intracranial aneurysm market growth include high treatment costs, limited access to healthcare facilities in underdeveloped and developing regions, and the risks associated with invasive surgical procedures. Along with these, stringent regulatory frameworks governing product approval and the need for skilled professionals capable of performing specialized interventions. However, the market witnessed new potential opportunities, including developing more effective and less invasive treatment techniques, applying artificial intelligence for enhanced imaging and diagnostics, and introducing novel biomaterials for stents and coils used in endovascular treatments. Furthermore, advancements in genetic research could lead to early detection and personalized treatment strategies.

Type: Demand for minimally invasive technique such as endovascular coiling for smaller, saccular aneurysms

Artery occlusion and bypass procedures are surgical interventions utilized when an intracranial aneurysm is considered too difficult or dangerous to treat with less invasive methods. These procedures involve closing off the affected artery and rerouting the blood flow using a vessel graft to preserve cerebral circulation. This technique is typically reserved for complex aneurysms that are not amenable to endovascular techniques or where previous treatments have failed. Endovascular coiling is a minimally invasive procedure that implicates inserting a catheter into an artery and navigating it to the aneurysm site. Soft metal coils are then deployed through the catheter into the aneurysm, promoting blood clotting and preventing blood flow into the aneurysm, thus reducing the risk of rupture. Endovascular coiling is often the preferred choice for treating many intracranial aneurysms due to its less invasive nature and reduced recovery time compared to open surgery. Flow diverters are endovascular devices designed to treat large and giant aneurysms and those with a wide base that is not suitable for coiling. These stent-like devices are placed across the neck of the aneurysm to redirect blood flow away from the aneurysm sac. Over time, this leads to thrombosis within the aneurysm and reconstruction of the affected vessel segment. Flow diverters are effective in occluding aneurysms while preserving blood flow in the parent artery. Surgical clipping is a traditional and definitive treatment for intracranial aneurysms that involves a craniotomy to expose the aneurysm. A neurosurgeon then places a small metal clip at the base of the aneurysm, effectively isolating it from the arterial blood flow. This prevents the aneurysm from growing or rupturing. While the procedure is invasive and requires a longer recovery period, it is a durable solution with a high long-term success rate.

End User: Rising patient flow across clinics for early screening and diagnostic services

Clinics, particularly those specializing in neurology and radiology, provide services for diagnosing and treating intracranial aneurysms. These facilities are usually smaller than hospitals and are often preferred by patients for early diagnosis, outpatient care, and convenience. Hospitals represent the most comprehensive end-use segment for intracranial aneurysm management, offering a full spectrum of diagnostic, surgical, and postoperative care. They are typically equipped with advanced neuroimaging technologies, such as high-resolution MRI and CT scanners, essential for the precise diagnosis and preoperative planning of aneurysm treatment. Hospitals facilitate open surgical procedures, such as microsurgical clipping, and endovascular therapies, such as coiling or flow diversion, conducted in well-equipped operating theaters with trained neuro-interventional radiologists and neurosurgeons. Post-treatment, hospitals provide intensive care units for monitoring patients, particularly after invasive surgeries or in the event of complications such as aneurysm rupture.

Regional Insights

In the Americas, the prevalence of intracranial aneurysms is influenced by a combination of genetic, environmental, and lifestyle factors. There is a substantial investment in healthcare infrastructure and research into neurological disorders, including intracranial aneurysms. The U.S. and Canada have advanced healthcare systems with high diagnosis and treatment rates, including surgical interventions and minimally invasive procedures. In the EMEA region, Europe has significant research and management of intracranial aneurysms, with many countries adopting modern endovascular treatments such as coiling and flow diversion. The Middle East has seen growth in healthcare infrastructure with the increasing availability of neurointerventional facilities. However, there are variations in prevalence and management approaches due to diverse socioeconomic and healthcare systems across the EMEA. Africa faces challenges due to limited healthcare resources, but there is ongoing progress in major urban centers. The Asia-Pacific region presents a varied landscape for intracranial aneurysms. Countries including Japan and South Korea have high technological adoption rates and a strong focus on innovation in medical treatments. Countries such as China and India are rapidly developing their healthcare infrastructure, improving access to neurovascular care.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Intracranial Aneurysm Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Intracranial Aneurysm Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Intracranial Aneurysm Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abbvie Inc., Acandis GmbH, Adeor Medical AG, B. Braun Melsungen AG, Balt Extrusion S.A., Bayer AG, Bristol-Myers Squibb Company, Cardiatis, S.A., Evasc Medical Systems Corp, F. Hoffmann-La Roche AG, Integra Lifesciences Holdings Corporation, Johnson & Johnson Services, Inc., Kaneka Corporation, Medtronic PLC, Merck & Co., Inc., Microport Scientific Corporation, Mizuho Medical Co,Ltd., Oxford Endovascular Ltd., Penumbra, Inc., Pfizer Inc., Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Intracranial Aneurysm Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Type
  • Artery Occlusion & Bypass
  • Endovascular Coiling
  • Flow Diverters
  • Surgical Clipping

• Indication
  • Ruptured Aneurysm
  • Unruptured Aneurysm

• End User
  • Clinics
  • Hospitals

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Intracranial Aneurysm Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Intracranial Aneurysm Market?

3. What are the technology trends and regulatory frameworks in the Intracranial Aneurysm Market?

4. What is the market share of the leading vendors in the Intracranial Aneurysm Market?

5. Which modes and strategic moves are suitable for entering the Intracranial Aneurysm Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising Prevalence of Cerebrovascular Disorder due to Changing Lifestyle
    • 5.1.1.2. Inclination for Minimally Invasive Intracranial Aneurysm Procedures
    • 5.1.1.3. Improved Diagnosis for Intracranial Aneurysm
  • 5.1.2. Restraints
    • 5.1.2.1. Side Effects Associated with Therapies and High Cost of Treatments
  • 5.1.3. Opportunities
    • 5.1.3.1. Rise in Research and Development Activities and Introduction of Innovative Technology Products
    • 5.1.3.2. Rising Potential for Endovascular Coiling
  • 5.1.4. Challenges
    • 5.1.4.1. Issues Related to Timing of Surgery and Anesthetic Induction
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Demand for minimally invasive technique such as endovascular coiling for smaller, saccular aneurysms
  • 5.2.2. End User: Rising patient flow across clinics for early screening and diagnostic services
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework Analysis
• 5.9. Client Customization

6. Intracranial Aneurysm Market, by Type

• 6.1. Introduction
• 6.2. Artery Occlusion & Bypass
• 6.3. Endovascular Coiling
• 6.4. Flow Diverters
• 6.5. Surgical Clipping

7. Intracranial Aneurysm Market, by Indication

• 7.1. Introduction
• 7.2. Ruptured Aneurysm
• 7.3. Unruptured Aneurysm

8. Intracranial Aneurysm Market, by End User

• 8.1. Introduction
• 8.2. Clinics
• 8.3. Hospitals

9. Americas Intracranial Aneurysm Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Intracranial Aneurysm Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Intracranial Aneurysm Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Evasc announces clinical milestones and plans to expand European presence with German subsidiary
  • 12.3.2. OU Researchers Designing Device to Improve Brain Aneurysm Treatment

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio